Evaluating the Impact of Parathyroidectomy and Bisphosphonate Therapy on Bone Mineral Density: Insights from a Multi-Institutional Study
Highlight
- Parathyroidectomy leads to a clinically meaningful improvement in total hip bone mineral density (BMD) in nearly half (45.2%) of patients within 3 years post-surgery.
- Bisphosphonate therapy started before or after parathyroidectomy did not significantly increase the rate of meaningful BMD improvement compared to surgery alone.
- The timing and additive benefit of bisphosphonates in enhancing skeletal recovery after parathyroidectomy remain unclear, highlighting a critical need for improved adjuvant therapies.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
